KR102151758B1 - Aromatic aroma composition for enhancing concentration of human brain and uses thereof - Google Patents

Aromatic aroma composition for enhancing concentration of human brain and uses thereof Download PDF

Info

Publication number
KR102151758B1
KR102151758B1 KR1020190019916A KR20190019916A KR102151758B1 KR 102151758 B1 KR102151758 B1 KR 102151758B1 KR 1020190019916 A KR1020190019916 A KR 1020190019916A KR 20190019916 A KR20190019916 A KR 20190019916A KR 102151758 B1 KR102151758 B1 KR 102151758B1
Authority
KR
South Korea
Prior art keywords
weight
oil
fragrance
increasing concentration
perfume
Prior art date
Application number
KR1020190019916A
Other languages
Korean (ko)
Other versions
KR20200102037A (en
Inventor
김성문
김민주
송지은
이차율
송운서
Original Assignee
강원대학교산학협력단
주식회사 라이프투게더
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강원대학교산학협력단, 주식회사 라이프투게더 filed Critical 강원대학교산학협력단
Priority to KR1020190019916A priority Critical patent/KR102151758B1/en
Publication of KR20200102037A publication Critical patent/KR20200102037A/en
Application granted granted Critical
Publication of KR102151758B1 publication Critical patent/KR102151758B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0069Heterocyclic compounds
    • C11B9/0073Heterocyclic compounds containing only O or S as heteroatoms
    • C11B9/008Heterocyclic compounds containing only O or S as heteroatoms the hetero rings containing six atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0003Compounds of unspecified constitution defined by the chemical reaction for their preparation
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0007Aliphatic compounds
    • C11B9/0015Aliphatic compounds containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0026Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/0034Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing six carbon atoms
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0042Essential oils; Perfumes compounds containing condensed hydrocarbon rings
    • C11B9/0046Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings
    • C11B9/0049Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms
    • C11B9/0053Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms both rings being six-membered
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 집중력 증가용 향료 조성물, 상기 향료 조성물을 포함하는 집중력 증가용 건강기능식품 및 화장료 조성물과 집중력 증가 효과를 지니는 향료 혼합물의 제조방법 및 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물에 관한 것으로, 본 발명의 향료 조성물은 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)의 증가를, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)의 증가를, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)의 증가를 유도하여 집중력 강화 효과가 있다.The present invention relates to a perfume composition for increasing concentration, a health functional food and cosmetic composition for increasing concentration including the perfume composition and a method for preparing a perfume mixture having an effect of increasing concentration, and a perfume mixture having an effect of increasing concentration prepared by the method As such, the fragrance composition of the present invention has an increase in RG (relative gamma power spectrum) in the central and right frontal lobes, an increase in RLB (relative low beta power spectrum) in the central and right frontal lobes, and SEF50 (Spectral edge) in the right frontal lobe frequency 50%) increases and has an effect of strengthening concentration.

Description

두뇌의 집중력을 향상시키는 아로마틱 향료 조성물 및 이의 용도{Aromatic aroma composition for enhancing concentration of human brain and uses thereof}Aromatic aroma composition for enhancing concentration of human brain and uses thereof

본 발명은 집중력 증가용 향료 조성물, 상기 향료 조성물을 포함하는 집중력 증가용 건강기능식품 및 화장료 조성물과 집중력 증가 효과를 지니는 향료 혼합물의 제조방법 및 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물에 관한 것이다.The present invention relates to a perfume composition for increasing concentration, a health functional food and cosmetic composition for increasing concentration including the perfume composition and a method for preparing a perfume mixture having an effect of increasing concentration, and a perfume mixture having an effect of increasing concentration prepared by the method will be.

향수는 휘발성의 향기 화합물 원료인 정유(essential oils)를 에탄올로 희석한 제품으로 이를 만드는데 들어가는 향료는 천연향료와 합성향료로 나뉜다. 천연향료는 동물로부터 얻는 동물향료와 식물로부터 얻는 식물향료로 나뉜다. 동물향료로는 향류고래로부터 얻는 앰버그리스(ambergris), 사향노루로부터 얻는 무스크(musk), 사향고양이로부터 얻는 시벳(vivette), 비버로부터 얻는 캐스토리움(castorium)이 있지만 요즈음은 잘 사용되고 있지 않다. 식물향료는 약 1,500여 종의 식물의 꽃, 잎, 과실, 종자, 수지, 뿌리, 줄기를 증류, 추출, 압착 등의 방법으로 얻을 수 있지만 순도가 낮고, 추출 및 증류시 향취 변화가 심하며, 생산지역, 수확시기 및 수확후 보관방법에 따라 강도와 품질변화가 심하며, 공급 불확실성이 크기 때문에 지금은 약 200여 종 정도가 시장에서 시판되고 있다.Perfume is a product obtained by diluting essential oils, a raw material of volatile fragrance compounds, with ethanol. The fragrances used to make them are divided into natural fragrances and synthetic fragrances. Natural fragrances are divided into animal fragrances obtained from animals and plant fragrances obtained from plants. Animal flavors include ambergris from sperm whales, musk from musk deer, vivette from musk cats, and castorium from beavers, but these days are not used well. Plant fragrances can be obtained by distilling, extracting, and compressing flowers, leaves, fruits, seeds, resins, roots, and stems of about 1,500 kinds of plants, but the purity is low, and the scent change is severe during extraction and distillation. Depending on the region, harvest time and post-harvest storage method, the intensity and quality vary greatly, and supply uncertainty is large, so about 200 species are currently on the market.

유기합성 향료는 실험실에서 유기합성을 통해 얻을 수 있는데 천연향보다는 순도가 높아 사용하기 저렴하고, 안정적이며 보존기간이 길고, 농도가 높으며, 계절적 공급에 문제가 없기 때문에 향료업계에서는 주로 많이 선호되고 있다. 유기합성 향료의 대표적인 예로는 샤넬 No.5에 사용되는 알데히드를 들 수 있다.Organic-synthetic fragrances can be obtained through organic synthesis in a laboratory. They are more pure than natural fragrances, so they are cheap to use, are stable, have a long shelf life, have a high concentration, and have no problems with seasonal supply, so they are mostly preferred in the fragrance industry. . Representative examples of organic synthetic fragrances include aldehydes used in Chanel No.5.

향료 하나하나는 각각의 독특하고 고유한 향취를 나타내는데 이를 향조 또는 노트라고 한다. 향조는 일반적으로 시트러스(citrus), 플로랄(floral), 그린(green), 프루티(fruity), 알데히드(aldehyde), 오리엔탈(oriental), 스파이시(spicy), 우디(woody), 시프레(psypre), 후제아(fougere), 마린(marine), 그리고 구루망(gourmand)으로 나타낸다. 향료를 여러 개를 섞으면 각각의 향료가 나타내는 향취가 변하게 된다. 단품 향료를 여러 개를 섞는 것을 조향이라고 하는데 이를 통해서 다양한 향취를 갖는 조합향료 제품을 만들 수 있다. 조합향료는 용도에 따라서 프래그런스(방향향료)와 플래버(식품향료)로 나뉜다. 프래그런스는 정유의 함유량에 따라 제품의 명칭은 향수(15-30%), 오 드 퍼퓸(15-18%), 오 드 토일렛(4-8%), 오 드 코롱(3-5%) 등으로 구분된다. 일반적으로 조합향료를 섞어 새로운 향료제품을 만들고자 할 때에는 뿌렸을 때 향이 즉시 나타나는 탑 노트, 향의 특징을 잘 나타내는 미들 노트, 그리고 향기에 깊이와 볼륨을 부여하는 라스트 노트가 상호 조화를 이루어야 한다.Each fragrance represents a unique and unique fragrance, which is called a fragrance or note. Flavor is generally citrus, floral, green, fruity, aldehyde, oriental, spicy, woody, psypre, and Denoted as fougere, marine, and gourmand. Mixing several flavors changes the scent of each flavor. Mixing several single flavors is called scent, and through this, you can make a combination fragrance product with a variety of flavors. Combination fragrances are divided into fragrance (fragrance) and flavor (food fragrance) depending on the purpose. According to the content of essential oils, fragrances are named perfume (15-30%), eau de parfum (15-18%), eau de toilette (4-8%), and eau de cologne (3-5%). It is distinguished. In general, when you want to make a new fragrance product by mixing combination fragrances, the top note that the fragrance immediately appears when sprayed, the middle note that shows the characteristics of the fragrance well, and the last note that gives depth and volume to the fragrance must be in harmony with each other.

인간이 향수를 흡입하게 되면 향기분자들이 비강을 따라 이동하여 후각수용체(olfactory receptors)와 결합하면 전기적인 신호가 발생한다. 이때 발생하는 전기적인 신호가 후구(olfactory bulb)에 있는 후각로(olfactory tract)를 따라 대뇌피질에 전달되면 뇌 활성화가 이루어진다. 향료에 함유된 냄새분자는 인간의 뇌에 영향을 주어 뇌파를 변화시키고 생리적, 심리적 변화를 유도하는 것으로 알려져 있다.When humans inhale perfume, scent molecules move along the nasal cavity and bind to olfactory receptors, generating electrical signals. When the electrical signal generated at this time is transmitted to the cerebral cortex along the olfactory tract in the olfactory bulb, the brain is activated. Smell molecules contained in perfume are known to affect the human brain to change brain waves and induce physiological and psychological changes.

대뇌피질이 어떤 자극에 의해 활성화가 이루어지면 뇌파(brain wave)가 발생하는데 뇌파는 인간의 대뇌피질의 신경계에서 뉴런들 사이에서 발생한 전기 신호이다. 두피에 대뇌 전기 활성을 증폭시킬 수 있는 전극을 붙이고 얻은 파형을 그래프로 기록하고 이를 분석하며 뇌의 자율적인 활동에 의하여 발생되는 전기적인 신호인 뇌파는 뇌의 활동을 기록하고 관찰함으로써 인간에 뇌에 관한 각성, 활성, 불안 및 안정 등의 인간의 정신 생리적 기능을 나타내주는 지표로 활용된다. 뇌파는 객관적, 비침습적, 연속적으로 기록하고 측정할 수 있는 장점을 가지고 있기 때문에 인지과학, 의학, 약학, 범죄조사 등에 활용되고 있다.When the cerebral cortex is activated by a certain stimulus, brain waves are generated, which are electrical signals generated between neurons in the nervous system of the human cerebral cortex. Electrodes that can amplify cerebral electrical activity are attached to the scalp, and the obtained waveform is recorded as a graph and analyzed. EEG, an electrical signal generated by the brain's autonomous activity, records and observes the activity of the brain. It is used as an indicator of human psychophysiological functions such as arousal, activity, anxiety and stability. Since EEG has the advantage of being able to record and measure objectively, non-invasively, and continuously, it is used in cognitive science, medicine, pharmacy, and criminal investigations.

뇌파는 주로 0~60 Hz 주파수와 5~300 uV의 진폭을 나타내는데 주파수의 범위에 따라 delta파(0~4 Hz), theta파(4~8 Hz), alpha파(8~13 Hz), beta파(13~30 Hz), gamma파(30~50 Hz)로 나뉜다. Delta파, theta파는 서파(slow wave)이며 두뇌 내부의 정보를 활용해 생각하고 활동할 시에 나타난다. Alpha파보다 높은 beta파는 속파(fast wave)이다. 뇌파분석에서는 절대 파워값(absolute power)뿐만 아니라 두개골의 두께 차이, 두피의 전기적 상태, 긴장도와 같은 개인차를 줄이고 정확한 뇌파반응을 분석할 수 있는 상대 파워값(relative power)이 사용된다.EEG mainly shows a frequency of 0 to 60 Hz and an amplitude of 5 to 300 uV, depending on the frequency range, delta wave (0 to 4 Hz), theta wave (4 to 8 Hz), alpha wave (8 to 13 Hz), beta It is divided into wave (13~30 Hz) and gamma wave (30~50 Hz). Delta waves and theta waves are slow waves and appear when you think and act using information inside your brain. Beta waves higher than Alpha waves are fast waves. In EEG analysis, not only absolute power, but also relative power, which can reduce individual differences such as skull thickness difference, scalp electrical state, and tension, and analyze accurate EEG responses, are used.

한국등록특허 제1349592호에는 심신을 이완시키고 안정을 유도하는 조합향료 조성물이 개시되어 있고, 한국공개특허 제2012-0131970호에는 스트레스 완화 및 진정효과를 갖는 향료 조성물이 개시되어 있으나, 본 발명의 두뇌의 집중력을 향상시키는 아로마틱 향료 조성물과는 상이하다.Korean Patent Registration No.1349592 discloses a combination perfume composition that relaxes the mind and body and induces stability, and Korean Patent Publication No. 2012-0131970 discloses a perfume composition having stress relief and soothing effects, but the brain of the present invention It is different from the aromatic fragrance composition that improves the concentration of the body.

본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 디하이드로 미르세놀, 리나룰, 리날릴 아세테이트, 메틸 팜플레모스, 버독스, 에틸 리나룰, 베타 이오논, 세드렘버, 릴리알, 아이소 이 수퍼, 칼론, 암브로픽스, 시스-3-헥세닐 실리실레이트, 헤디온, 갈락솔라이드, 토날라이드, 헬리오날, 박다놀, 레몬 오일, 시더우드 오일, 로즈마리 오일, 버가못 오일, 디프로필렌 글리콜 및 블랙페퍼 오일의 24가지 물질을 포함하는 향료 조성물이 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)의 증가를, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)의 증가를, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)의 증가를 유도하는 것을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above requirements, and the inventors of the present invention provide dihydro myrcenol, linalul, linalyl acetate, methyl pamplemos, verdox, ethyl linalul, beta ionone, cedrember, lilyal, Isoi Super, Calon, Ambrofix, Cis-3-Hexenyl Silicylate, Hedione, Galaxolide, Tonalide, Helional, Bakdanol, Lemon Oil, Cedarwood Oil, Rosemary Oil, Bergamot Oil, D A fragrance composition containing 24 substances of propylene glycol and black pepper oil showed an increase in the relative gamma power spectrum (RG) in the central and right frontal lobe, and the relative low beta power spectrum (RLB) in the central and right frontal lobe. , By confirming inducing an increase in SEF50 (Spectral edge frequency 50%) in the right frontal lobe, the present invention was completed.

상기 과제를 해결하기 위해, 본 발명은 디하이드로 미르세놀, 리나룰, 리날릴 아세테이트, 메틸 팜플레모스, 버독스, 에틸 리나룰, 베타 이오논, 세드렘버, 릴리알, 아이소 이 수퍼, 칼론, 암브로픽스, 시스-3-헥세닐 실리실레이트, 헤디온, 갈락솔라이드, 토날라이드, 헬리오날, 박다놀, 레몬 오일, 시더우드 오일, 로즈마리 오일, 버가못 오일, 디프로필렌 글리콜 및 블랙페퍼 오일이 혼합된 향료 혼합물을 유효성분으로 함유하는 집중력 증가용 향료 조성물을 제공한다.In order to solve the above problems, the present invention provides dihydro myrsenol, linalul, linalyl acetate, methyl pamplemos, verdox, ethyl linalul, beta ionone, cedrember, lilial, isoi super, calon, Ambrofix, cis-3-hexenyl silicylate, hedione, galaxolide, tonalide, helional, bakdanol, lemon oil, cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a perfume composition for increasing concentration containing the mixed perfume mixture as an active ingredient.

또한, 본 발명은 상기 향료 조성물을 포함하는 집중력 증가용 건강기능식품을 제공한다.In addition, the present invention provides a health functional food for increasing concentration comprising the fragrance composition.

또한, 본 발명은 상기 향료 조성물을 포함하는 집중력 증가용 화장료 조성물을 제공한다.In addition, the present invention provides a cosmetic composition for increasing concentration comprising the perfume composition.

또한, 본 발명은 디하이드로 미르세놀, 리나룰, 리날릴 아세테이트, 메틸 팜플레모스, 버독스, 에틸 리나룰, 베타 이오논, 세드렘버, 릴리알, 아이소 이 수퍼, 칼론, 암브로픽스, 시스-3-헥세닐 실리실레이트, 헤디온, 갈락솔라이드, 토날라이드, 헬리오날, 박다놀, 레몬 오일, 시더우드 오일, 로즈마리 오일, 버가못 오일, 디프로필렌 글리콜 및 블랙페퍼 오일을 혼합하여 제조하는 것을 특징으로 하는 집중력 증가 효과를 지니는 향료 혼합물의 제조방법을 제공한다.In addition, the present invention is dihydro myrsenol, linalul, linalyl acetate, methyl pamphlemos, verdox, ethyl linalul, beta ionone, cedrember, lilial, isoi super, calon, ambrofix, cis -3-Hexenyl silicylate, hedione, galaxolide, tonalide, helional, bakdanol, lemon oil, cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a method for producing a flavor mixture having a concentration increasing effect, characterized in that.

또한, 본 발명은 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물을 제공한다.In addition, the present invention provides a fragrance mixture having an effect of increasing concentration prepared by the above method.

본 발명의 향료 조성물은 향료 흡입을 통해, 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)가 증가하고, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)가 증가하고, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)가 증가하여 집중력을 높이는 효과를 얻을 수 있다. 또한, 본 발명의 향료 조성물은 향장 향료(fragrance)와 식품 향료(flavor) 등의 원료로 사용할 수 있어 다양한 향장산업용 제품에 이용될 수 있을 뿐만 아니라, 식품에 첨가하여 집중력을 높이는 기능의 뉴로푸드(NeuroFood)의 개발에도 활용될 수 있다.The perfume composition of the present invention increases the relative gamma power spectrum (RG) in the central frontal lobe and the right frontal lobe, increases the RLB (Relative low beta power spectrum) in the central frontal lobe and the right frontal lobe, and SEF50 in the right frontal lobe. (Spectral edge frequency 50%) can be increased to increase concentration. In addition, the fragrance composition of the present invention can be used as a raw material such as fragrance and food flavor, so it can be used not only in a variety of products for the fragrance industry, but also added to food to increase concentration. NeuroFood) can also be used.

도 1은 뇌파측정을 위해 인간의 두뇌에 전극을 붙이는 부위를 제시한 10-20 국제표준 전극부착법을 보여주는 사진이다.
도 2는 피험자의 두뇌에 뇌전도(electroencephalogram, EEG)용 모자를 씌우고 뇌파를 측정하는 모습을 보여주는 사진이다.
1 is a photograph showing a 10-20 international standard electrode attachment method showing a region where electrodes are attached to a human brain for EEG measurements.
FIG. 2 is a photograph showing an electroencephalogram (EEG) cap on a subject's brain and measuring an EEG.

본 발명의 목적을 달성하기 위하여, 본 발명은 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리날릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol) 및 블랙페퍼 오일(black pepper oil)이 혼합된 향료 혼합물을 유효성분으로 함유하는 집중력 증가용 향료 조성물을 제공한다.In order to achieve the object of the present invention, the present invention is dihydro myrcenol (dihydro myrcenol), linalool (linalool), linalyl acetate (linalyl acetate), methyl pamplemousse (methyl pamplemousse), verdox (verdox), Ethyl linalool, beta ionone, cedramber, lilial, iso e super, calone, ambrofix, cis -3-hexenyl salicylate (cis-3-hexenyl salicylate), hedione, galaxolide (50 ipm), tonalide (helional), bacdanol (bacdanol), A flavoring mixture of lemon oil, cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a fragrance composition for increasing concentration containing as an active ingredient.

본 발명의 향료 조성물에서, 상기 향료 혼합물은 바람직하게는 디하이드로 미르세놀(dihydro myrcenol) 2.2~2.8 중량%, 리나룰(linalool) 0.8~1.2 중량%, 리날릴 아세테이트(linalyl acetate) 0.8~1.2 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.3~2.7 중량%, 버독스(verdox) 2.8~3.2 중량%, 에틸 리나룰(ethyl linalool) 1.3~1.7 중량%, 베타 이오논(beta ionone) 2.8~3.2 중량%, 세드렘버(cedramber) 1.7~2.1 중량%, 릴리알(lilial) 7.7~8.3 중량%, 아이소 이 수퍼(iso e super) 9.2~9.8 중량%, 칼론(calone) 0.35~0.45 중량%, 암브로픽스(ambrofix) 1.8~2.2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.3~3.7 중량%, 헤디온(hedione) 10~11 중량%, 갈락솔라이드(galaxolide 50 ipm) 9.5~10.5 중량%, 토날라이드(tonalide) 3.5~4.5 중량%, 헬리오날(helional) 0.4~0.6 중량%, 박다놀(bacdanol) 0.8~1.2 중량%, 레몬 오일(lemon oil) 4.7~5.3 중량%, 시더우드 오일(cedarwood oil) 0.8~1.2 중량%, 로즈마리 오일(rosemary oil) 0.8~1.2 중량%, 버가못 오일(bergamot oil) 0.8~1.2 중량%, 디프로필렌 글리콜(dipropylene glycol) 25~26.5 중량% 및 블랙페퍼 오일(black pepper oil) 0.4~0.6 중량%로 이루어진 것일 수 있으며,In the perfume composition of the present invention, the perfume mixture is preferably dihydro myrcenol 2.2 to 2.8 wt%, linalool 0.8 to 1.2 wt%, linalyl acetate 0.8 to 1.2 wt% %, methyl pamplemousse 2.3~2.7 wt%, verdox 2.8~3.2 wt%, ethyl linalool 1.3~1.7 wt%, beta ionone 2.8~3.2 Wt%, Cedramber 1.7~2.1 wt%, lilial 7.7~8.3 wt%, isoe super 9.2~9.8 wt%, Calone 0.35~0.45 wt%, cancer Brofix 1.8 to 2.2 wt%, cis-3-hexenyl salicylate 3.3 to 3.7 wt%, hedione 10 to 11 wt%, galaxolide 50 ipm) 9.5 to 10.5 wt%, tonalide 3.5 to 4.5 wt%, helial 0.4 to 0.6 wt%, bacdanol 0.8 to 1.2 wt%, lemon oil 4.7 to 5.3 wt%, cedarwood oil 0.8~1.2 wt%, rosemary oil 0.8~1.2 wt%, bergamot oil 0.8~1.2 wt%, dipropylene glycol 25~ It may be composed of 26.5% by weight and 0.4 to 0.6% by weight of black pepper oil,

더욱 바람직하게는 디하이드로 미르세놀(dihydro myrcenol) 2.5 중량%, 리나룰(linalool) 1 중량%, 리날릴 아세테이트(linalyl acetate) 1 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.5 중량%, 버독스(verdox) 3 중량%, 에틸 리나룰(ethyl linalool) 1.5 중량%, 베타 이오논(beta ionone) 3 중량%, 세드렘버(cedramber) 1.9 중량%, 릴리알(lilial) 8 중량%, 아이소 이 수퍼(iso e super) 9.5 중량%, 칼론(calone) 0.4 중량%, 암브로픽스(ambrofix) 2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.5 중량%, 헤디온(hedione) 10.5 중량%, 갈락솔라이드(galaxolide 50 ipm) 10 중량%, 토날라이드(tonalide) 4 중량%, 헬리오날(helional) 0.5 중량%, 박다놀(bacdanol) 1 중량%, 레몬 오일(lemon oil) 5 중량%, 시더우드 오일(cedarwood oil) 1 중량%, 로즈마리 오일(rosemary oil) 1 중량%, 버가못 오일(bergamot oil) 1 중량%, 디프로필렌 글리콜(dipropylene glycol) 25.7 중량% 및 블랙페퍼 오일(black pepper oil) 0.5 중량%로 이루어진 것일 수 있다.More preferably dihydro myrcenol (dihydro myrcenol) 2.5% by weight, linalool (linalool) 1% by weight, linalyl acetate (linalyl acetate) 1% by weight, methyl pamplemousse (methyl pamplemousse) 2.5% by weight, Burdox (verdox) 3 wt%, ethyl linalool 1.5 wt%, beta ionone 3 wt%, cedramber 1.9 wt%, lilial 8 wt%, isoi super (iso e super) 9.5 wt%, calone 0.4 wt%, ambrofix 2 wt%, cis-3-hexenyl salicylate 3.5 wt%, hedione (hedione) 10.5% by weight, galaxolide (50 ipm) 10% by weight, tonalide (tonalide) 4% by weight, helional (helional) 0.5% by weight, bacdanol (bacdanol) 1% by weight, lemon oil (lemon oil) 5% by weight, cedarwood oil 1% by weight, rosemary oil 1% by weight, bergamot oil 1% by weight, dipropylene glycol 25.7% by weight and black pepper Oil (black pepper oil) may be made of 0.5% by weight.

본 발명의 향료 조성물은 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)의 증가를, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)의 증가를, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)의 증가를 유도하여 집중력 증가 효과를 나타내는 것을 특징으로 한다.The fragrance composition of the present invention has an increase in RG (relative gamma power spectrum) in the central and right frontal lobes, an increase in RLB (relative low beta power spectrum) in the central and right frontal lobes, and SEF50 (Spectral edge frequency 50) in the right frontal lobe. %) to increase concentration.

RG는 전체 중 Gamma파의 비율을 의미하며, Gamma파는 추리, 판단 등의 고도의 인지작용 시 활성화된다고 알려져 있다. RLB는 전체에서 low beta파의 비율을 의미하는 것이고, beta파는 일반적인 작업을 하거나 의식적인 행동을 할 때 나타나며 정신활동이 있을 때 활성화된다. SEF50은 특정 주파수 값까지의 면적이 주파수 영역에 대한 면적의 50%를 차지하는 해당 특정 주파수 값을 의미한다.RG means the ratio of Gamma waves among the total, and Gamma waves are known to be activated during highly cognitive actions such as reasoning and judgment. RLB refers to the ratio of low beta waves in the whole, and beta waves appear when you perform general tasks or conscious actions, and are activated when there is mental activity. SEF50 means a specific frequency value in which the area up to a specific frequency value occupies 50% of the area for the frequency domain.

본 발명은 또한, 본 발명은 향료 조성물을 포함하는 집중력 증가용 건강기능식품을 제공한다.The present invention also provides a health functional food for increasing concentration comprising a perfume composition.

상기 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 및 천연 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. The health functional food includes various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavoring agents, coloring agents and enhancers (cheese, chocolate, etc.), pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, It may contain pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonates used in carbonated beverages, and the like. In addition, it may contain pulp for the manufacture of natural fruit juices and vegetable beverages. These components may be used independently or in combination.

본 발명의 건강기능식품은 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다.The health functional food of the present invention may contain various flavoring agents or natural carbohydrates as additional ingredients. The natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as taumatin and stevia extract, and synthetic sweeteners such as saccharin and aspartame can be used.

본 발명은 또한, 본 발명의 향료 조성물을 포함하는 집중력 증가용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for increasing concentration comprising the perfume composition of the present invention.

상기 화장료 조성물은 유연화장수, 수렴화장수, 영양화장수, 영양로션, 영양에센스, 영양크림, 마사지크림, 에센스, 아이크림, 아이에센스, 클렌징크림, 클렌징폼, 클렌징워터, 팩, 젤, 파우더, 메이크업베이스, 바디로션, 바디크림, 바디오일, 바디에센스, 로션, 연고, 겔, 크림, 패취 및 분무제로 이루어진 군에서 선택되는 제형을 갖는 것이 바람직하지만 이에 한정하지 않는다.The cosmetic composition is a softening lotion, astringent lotion, nourishing lotion, nourishing lotion, nourishing essence, nourishing cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing foam, cleansing water, pack, gel, powder, makeup base , Body lotion, body cream, body oil, body essence, lotion, ointment, gel, cream, patch, and spray, it is preferable to have a formulation selected from the group consisting of, but is not limited thereto.

본 발명은 또한, 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리날릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol) 및 블랙페퍼 오일(black pepper oil)을 혼합하여 제조하는 것을 특징으로 하는 집중력 증가 효과를 지니는 향료 혼합물의 제조방법을 제공한다.The present invention also provides dihydro myrcenol, linalool, linalyl acetate, methyl pamplemousse, verdox, ethyl linalool , Beta ionone, cedramber, lilial, iso e super, calone, ambrofix, cis-3-hexenyl silicyl Rate (cis-3-hexenyl salicylate), hedione, galaxolide (50 ipm), tonalide, helional (helional), bacdanol, lemon oil, The effect of increasing concentration, characterized by mixing cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a method for producing a flavor mixture having a.

본 발명의 집중력 증가 효과를 지니는 향료 혼합물의 제조방법은, 보다 구체적으로는 향료 혼합물 총 중량 기준으로, 디하이드로 미르세놀(dihydro myrcenol) 2.2~2.8 중량%, 리나룰(linalool) 0.8~1.2 중량%, 리날릴 아세테이트(linalyl acetate) 0.8~1.2 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.3~2.7 중량%, 버독스(verdox) 2.8~3.2 중량%, 에틸 리나룰(ethyl linalool) 1.3~1.7 중량%, 베타 이오논(beta ionone) 2.8~3.2 중량%, 세드렘버(cedramber) 1.7~2.1 중량%, 릴리알(lilial) 7.7~8.3 중량%, 아이소 이 수퍼(iso e super) 9.2~9.8 중량%, 칼론(calone) 0.35~0.45 중량%, 암브로픽스(ambrofix) 1.8~2.2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.3~3.7 중량%, 헤디온(hedione) 10~11 중량%, 갈락솔라이드(galaxolide 50 ipm) 9.5~10.5 중량%, 토날라이드(tonalide) 3.5~4.5 중량%, 헬리오날(helional) 0.4~0.6 중량%, 박다놀(bacdanol) 0.8~1.2 중량%, 레몬 오일(lemon oil) 4.7~5.3 중량%, 시더우드 오일(cedarwood oil) 0.8~1.2 중량%, 로즈마리 오일(rosemary oil) 0.8~1.2 중량%, 버가못 오일(bergamot oil) 0.8~1.2 중량%, 디프로필렌 글리콜(dipropylene glycol) 25~26.5 중량% 및 블랙페퍼 오일(black pepper oil) 0.4~0.6 중량%를 혼합하여 제조할 수 있으며,The method for producing a perfume mixture having an effect of increasing concentration of the present invention is more specifically, based on the total weight of the perfume mixture, dihydro myrcenol 2.2 to 2.8 wt%, linalool 0.8 to 1.2 wt% , Linalyl acetate 0.8 to 1.2 wt%, methyl pamplemousse 2.3 to 2.7 wt%, verdox 2.8 to 3.2 wt%, ethyl linalool 1.3 to 1.7 wt %, beta ionone 2.8-3.2 wt%, cedramber 1.7-2.1 wt%, lilial 7.7-8.3 wt%, isoe super 9.2-9.8 wt% , Calone 0.35 to 0.45 wt%, ambrofix 1.8 to 2.2 wt%, cis-3-hexenyl salicylate 3.3 to 3.7 wt%, hedione ) 10-11 wt%, galaxolide 50 ipm 9.5-10.5 wt%, tonalide 3.5-4.5 wt%, helial 0.4-0.6 wt%, bacdanol 0.8- 1.2 wt%, lemon oil 4.7~5.3 wt%, cedarwood oil 0.8~1.2 wt%, rosemary oil 0.8~1.2 wt%, bergamot oil 0.8~1.2 It can be prepared by mixing wt%, dipropylene glycol 25~26.5 wt% and black pepper oil 0.4~0.6 wt%,

더욱 구체적으로는 향료 혼합물 총 중량 기준으로, 디하이드로 미르세놀(dihydro myrcenol) 2.5 중량%, 리나룰(linalool) 1 중량%, 리날릴 아세테이트(linalyl acetate) 1 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.5 중량%, 버독스(verdox) 3 중량%, 에틸 리나룰(ethyl linalool) 1.5 중량%, 베타 이오논(beta ionone) 3 중량%, 세드렘버(cedramber) 1.9 중량%, 릴리알(lilial) 8 중량%, 아이소 이 수퍼(iso e super) 9.5 중량%, 칼론(calone) 0.4 중량%, 암브로픽스(ambrofix) 2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.5 중량%, 헤디온(hedione) 10.5 중량%, 갈락솔라이드(galaxolide 50 ipm) 10 중량%, 토날라이드(tonalide) 4 중량%, 헬리오날(helional) 0.5 중량%, 박다놀(bacdanol) 1 중량%, 레몬 오일(lemon oil) 5 중량%, 시더우드 오일(cedarwood oil) 1 중량%, 로즈마리 오일(rosemary oil) 1 중량%, 버가못 오일(bergamot oil) 1 중량%, 디프로필렌 글리콜(dipropylene glycol) 25.7 중량% 및 블랙페퍼 오일(black pepper oil) 0.5 중량%를 혼합하여 제조할 수 있다.More specifically, based on the total weight of the fragrance mixture, dihydro myrcenol 2.5% by weight, linalool 1% by weight, linalyl acetate 1% by weight, methyl pamplemousse ) 2.5 wt%, verdox 3 wt%, ethyl linalool 1.5 wt%, beta ionone 3 wt%, cedramber 1.9 wt%, lilial 8% by weight, iso e super (9.5% by weight), calone (0.4% by weight), ambrofix (2% by weight), cis-3-hexenyl silicylate (cis-3-hexenyl salicylate) ) 3.5 wt%, hedione 10.5 wt%, galaxolide 50 ipm 10 wt%, tonalide 4 wt%, helial 0.5 wt%, bacdanol 1 Wt%, lemon oil 5 wt%, cedarwood oil 1 wt%, rosemary oil 1 wt%, bergamot oil 1 wt%, dipropylene glycol ) It can be prepared by mixing 25.7% by weight and 0.5% by weight of black pepper oil.

본 발명은 또한, 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물을 제공한다.The present invention also provides a fragrance mixture having an effect of increasing concentration prepared by the above method.

이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are only illustrative of the present invention, and the contents of the present invention are not limited to the following examples.

향료 시료의 준비Preparation of fragrance samples

본 발명의 아로마틱 마린 토닉 향료를 개발하는데 사용된 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리나릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스 쓰리 헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol)은 카스넘버(CAS Number)가 명확하게 명기된 시료를 국내의 원료공급업체로부터 구입하였다.Dihydro myrcenol, linalool, linalyl acetate, methyl pamplemousse, verdox, used to develop the aromatic marine tonic fragrance of the present invention Ethyl linalool, beta ionone, cedramber, lilial, iso e super, calone, ambrofix, cis Three hexenyl silicylate (cis-3-hexenyl salicylate), hedione, galaxolide (50 ipm), tonalide (helional), bacdanol (bacdanol), lemon oil (lemon oil), cedarwood oil, rosemary oil, bergamot oil, and dipropylene glycol are samples whose CAS Number is clearly specified. Purchased from a raw material supplier.

그리고 블랙페퍼 오일(blackpepper oil)은 수증기증류장치(EssenLab-Plus, HANIL LABTECH, Korea)를 사용하여 수행하였다. 수증기 증류장치의 수증기 발생부위에 2 L의 증류수를 넣고, 정유 발생부위에 블랙페퍼 시료 1 kg를 넣은 다음, 냉각관에는 4℃의 냉각수가 지속적으로 흐르도록 하였다. 수증기 발생부위의 온도를 100℃로 90분간 유지시키면서 수증기를 발생시켰고, 블랙페퍼에 함유된 정유는 냉각관에서 응축된 후 수용기에서 증류수층과 정유층으로 모였다. 순수한 정유만을 모으기 위하여 정유층을 무수황산나트륨이 담겨있는 삼각깔대기에 통과시켜 수분과 불순물을 제거시켰으며, 수집된 정유는 4℃의 냉장고에서 보관하였다.And black pepper oil (blackpepper oil) was carried out using a steam distillation apparatus (EssenLab-Plus, HANIL LABTECH, Korea). 2 L of distilled water was put in the steam generating part of the steam distillation apparatus, 1 kg of black pepper sample was put in the generating part of the refinery, and then the cooling water of 4℃ was continuously flowed through the cooling pipe. Water vapor was generated while maintaining the temperature of the steam generating part at 100°C for 90 minutes, and the essential oil contained in the black pepper was condensed in a cooling tube and then collected in a distilled water layer and a refined oil layer in the receiver. In order to collect only pure essential oil, the essential oil layer was passed through a triangular funnel containing anhydrous sodium sulfate to remove moisture and impurities, and the collected essential oil was stored in a refrigerator at 4℃.

제조예Manufacturing example 1. One. 아로마틱Aromatic 마린Marine 토닉tonic 향취의 향료 조성물 개발 Development of fragrance composition of fragrance

본 발명의 아로마틱 마린 토닉 향취는 시원한 바다의 향취와 풍부한 아로마의 향기가 주는 느낌이 복합적으로 표현된 것이다. 신규의 아로마틱 마린 토닉 향취를 갖는 조성물을 개발하기 위하여 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리나릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스 쓰리 헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol), 블랙페퍼 오일(black pepper oil)을 하기 표 1과 같이 혼합하여 7종을 개발하였다.The aromatic marine tonic scent of the present invention is a complex expression of the scent of the cool sea and the scent of rich aroma. To develop a composition having a novel aromatic marine tonic scent, dihydro myrcenol, linalool, linalyl acetate, methyl pamplemousse, and verdox , Ethyl linalool, beta ionone, cedramber, lilial, iso e super, calone, ambrofix, Cis-3-hexenyl salicylate, hedione, galaxolide 50 ipm, tonalide, helional, bacdanol, lemon Oil (lemon oil), cedarwood oil (cedarwood oil), rosemary oil (rosemary oil), bergamot oil (bergamot oil), dipropylene glycol (dipropylene glycol), black pepper oil (black pepper oil) as shown in Table 1 below. Seven kinds were developed by mixing.

신규의 아로마틱 마린 토닉 향료 개발을 위한 조성물과 조성비Composition and composition ratio for developing new aromatic marine tonic fragrance 향료 성분 Flavoring ingredients 조합
향료
1
Combination
Spices
One
조합
향료
2
Combination
Spices
2
조합
향료
3
Combination
Spices
3
조합
향료
4
Combination
Spices
4
조합
향료
5
Combination
Spices
5
조합
향료
6
Combination
Spices
6
조합
향료
7
Combination
Spices
7
1One dihydro myrcenoldihydro myrcenol 1.51.5 1.51.5 1.01.0 1.01.0 2.52.5 2.52.5 2.02.0 22 linaloollinalool 0.50.5 0.50.5 2.02.0 2.02.0 1.01.0 1.01.0 1.01.0 33 linalyl acetatelinalyl acetate 1.51.5 1.51.5 2.02.0 2.02.0 0.50.5 1.01.0 1.01.0 44 methyl pamplemoussemethyl pamplemousse 3.03.0 3.03.0 1.51.5 1.51.5 2.52.5 2.52.5 2.52.5 55 verdoxverdox 5.05.0 5.05.0 4.04.0 4.04.0 3.03.0 3.03.0 2.02.0 66 ethyl linaloolethyl linalool 0.50.5 0.50.5 1.01.0 1.01.0 1.51.5 1.51.5 1.51.5 77 beta-iononebeta-ionone 1.01.0 1.01.0 2.02.0 2.02.0 3.03.0 3.03.0 2.02.0 88 cedrambercedramber 0.50.5 1.01.0 1.01.0 1.21.2 1.21.2 1.91.9 0.50.5 99 liliallilial 10.010.0 10.010.0 7.07.0 7.07.0 8.08.0 8.08.0 9.09.0 1010 iso e superiso e super 8.08.0 9.59.5 8.58.5 9.59.5 9.09.0 9.59.5 10.010.0 1111 calonecalone 0.10.1 0.10.1 0.30.3 0.30.3 0.20.2 0.40.4 0.40.4 1212 ambrofixambrofix 3.53.5 3.53.5 2.02.0 2.02.0 2.52.5 2.02.0 1.51.5 1313 cis-3-hexenyl slicylatecis-3-hexenyl slicylate 2.02.0 2.02.0 2.52.5 2.52.5 3.53.5 3.53.5 4.54.5 1414 hedionhedion 8.58.5 8.58.5 9.59.5 9.59.5 10.510.5 10.510.5 12.512.5 1515 galaxolide 50 ipmgalaxolide 50 ipm 11.011.0 11.011.0 11.511.5 11.511.5 10.010.0 10.010.0 9.09.0 1616 tonalidetonalide 4.04.0 4.04.0 3.03.0 3.03.0 2.02.0 4.04.0 2.02.0 1717 helionalhelional 1.01.0 1.01.0 1.01.0 0.50.5 0.50.5 0.50.5 0.50.5 1818 bacdanolbacdanol 1.51.5 1.51.5 1.51.5 1.51.5 1.01.0 1.01.0 1.01.0 1919 lemon oillemon oil 4.04.0 4.04.0 4.54.5 4.54.5 5.05.0 5.05.0 5.55.5 2020 cedarwood oilcedarwood oil 1.51.5 1.51.5 1.51.5 1.51.5 1.01.0 1.01.0 1.01.0 2121 rosemary oilrosemary oil 0.50.5 0.50.5 0.50.5 1.01.0 1.01.0 1.01.0 1.01.0 2222 bergamot oilbergamot oil 1.91.9 1.91.9 1.01.0 1.01.0 1.31.3 1.01.0 1.31.3 2323 dipropylene glycoldipropylene glycol 29.029.0 27.027.0 31.231.2 30.030.0 29.329.3 25.725.7 28.328.3 2424 black pepper oilblack pepper oil 0.50.5 1.01.0 1.01.0 0.50.5 1.01.0 0.50.5 1.01.0 합계Sum 100100 100100 100100 100100 100100 100100 100100

실시예Example 1. One. 아로마틱Aromatic 마린Marine 토닉tonic 향료 조성물에 대한 소비자 선호도 조사 Consumer preference survey for perfume composition

본 제조예 1에서 조향된 7개의 조합향료에 대한 선호도 조사를 10-30대의 일반 소비자 50명을 대상으로 시향지(0.5 cm × 13 cm)에 적신 다음, 코로부터 5 cm 되는 위치에서 향을 맡게 하고 가장 선호하는 향료에 10점, 가장 비선호하는 향료에 0점을 주도록 하였다. 선호도 결과를 바탕으로 평균값을 구하였고, 이를 표 2에 나타내었다. The preference survey for the 7 combination perfumes steered in Preparation Example 1 was conducted for 50 general consumers in their 10s and 30s, soaked in a vision paper (0.5 cm × 13 cm), and smelled at a position 5 cm from the nose. The most preferred fragrance was given 10 points and the most unfavorable fragrance was given 0 points. The average value was calculated based on the preference result, and it is shown in Table 2.

아로마틱 마린 토닉 향취 조성물 7종에 대한 선호도 조사 결과 조합향료 6의 조성물이 8.9점으로 가장 높은 점수를 나타내어 선호도가 가장 높게 나타났고, 선호도가 가장 낮았던 것은 조합향료 5로 선호도가 3.4점으로 나타났다.As a result of the preference survey for 7 kinds of aromatic marine tonic fragrance composition, the composition of the combination perfume 6 showed the highest score with 8.9 points, and the preference was the highest, and the lowest preference was the combination perfume 5 with a preference of 3.4 points.

조합향료 7종에 대한 소비자 선호도Consumer Preference for 7 Combination Flavors 소비자 선호도Consumer preference 조합향료 1Combination spices 1 조합향료 2Combination spices 2 조합향료 3Combination spices 3 조합향료 4Combination spices 4 조합향료 5Combination spices 5 조합향료 6Combination fragrance 6 조합향료 7Combination spices 7 평균값medium 3.43.4 7.37.3 5.45.4 8.08.0 3.43.4 8.98.9 6.46.4

실시예Example 2. 2. 아로마틱Aromatic 마린Marine 토닉tonic 향취의 조합향료 6이 인간의 뇌파에 미치는 영향 The Effect of Fragrance 6 of Fragrance on Human EEG

실시예 1을 통하여 소비자 선호도가 가장 높았던 조합향료 6을 흡입시에 인간의 뇌 활동에는 어떠한 영향을 미치는지를 알기 위하여 뇌파(Electroencephalogram, EEG)를 측정하였다. 뇌파측정은 최대한 잡음이 혼입되지 않은 온도 23℃, 습도 50%가 유지되는 32.4 m2 크기의 실험실에서 남녀 각각 10명씩 총 20명의 피험자를 대상으로 수행하였다.EEG (Electroencephalogram, EEG) was measured to find out what effect the combination perfume 6, which had the highest consumer preference, on human brain activity when inhaled through Example 1. EEG measurements were performed on a total of 20 subjects, 10 males and females each, in a 32.4 m 2 laboratory with a temperature of 23° C. and 50% humidity in which noise was not mixed as much as possible.

본 실시예에서 뇌파측정을 위해 사용한 뇌파측정기기는 QEEG-32 System (LAXTHA Inc. Korea)이었으며, 피험자의 뇌파신호 측정은 LAXTHA의 데이터 수집 장비 및 분석프로그램(Telescan)을 이용하였다. 피험자들에게 10~20 국제표준 전극 부착법을 이용하여 32개의 접지전극을 뇌파전용 Electro-Gel(Electro-Cap Internationals, Inc. U.S.A.)을 사용하여 좌측과 우측 전전두엽(Fp1, Fp2, Fpz, Af3, Af4, Afz), 좌측과 우측 전두엽(F3, F4, F7, F8, Fz, Fc1, Fc2, Fc5, Fc6), 좌측과 우측 측두엽(T3, T4, T7, T8, Cp5, Cp6), 좌측과 우측 두정엽(P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), 좌측과 우측 후두엽(O1, O2, Oz) 부분에 부착하고 왼쪽과 오른쪽 귓볼에도 각각 하나씩의 레퍼런스 전극을 부착하였다. 윗면 지름 5 cm, 높이 4.8 cm, 아랫면 지름 3.5 cm의 종이컵에 가로 3.5 cm, 세로 4 cm의 거즈를 넣고 피펫을 이용해 향료를 첨가하여 거즈에 고루 뭍인 후, 피험자의 코로부터 약 5 cm 거리를 유지하고 피험자가 눈을 감은 상태에서 아로마틱 마린 토닉 조합향료 6 흡입 전(무자극)과 흡입 상태(향자극)로 하여 각각 60초씩 측정하였다.In this example, the EEG measurement device used for EEG measurement was the QEEG-32 System (LAXTHA Inc. Korea), and the data collection equipment and analysis program (Telescan) of LAXTHA were used to measure the EEG signal of the subject. To the subjects, 32 grounding electrodes were attached to the left and right frontal lobes (Fp1, Fp2, Fpz, Af3, Af4) using Electro-Gel (Electro-Cap Internationals, Inc. USA) for EEG using 10-20 international standard electrode attachment method. , Afz), left and right frontal lobes (F3, F4, F7, F8, Fz, Fc1, Fc2, Fc5, Fc6), left and right temporal lobes (T3, T4, T7, T8, Cp5, Cp6), left and right parietal lobes (P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), left and right occipital lobes (O1, O2, Oz) were attached, and one reference electrode was attached to the left and right earlobe, respectively. Put gauze 3.5 cm wide and 4 cm long into a paper cup with a top diameter of 5 cm, a height of 4.8 cm, and a bottom diameter of 3.5 cm, add flavoring using a pipette, and spread it evenly on the gauze, keeping a distance of about 5 cm from the subject's nose. The subjects were measured for 60 seconds each before inhalation (no stimulation) and inhalation condition (scent stimulation) with the subject's eyes closed.

본 실시예에서 아로마틱 마린 토닉 조합향료 6에 대한 뇌파측정을 통해 얻어진 데이터 처리는 피험자의 뇌파신호 중 대표적인 50초간의 뇌파신호만을 추출하여 뇌파일괄처리 프로그램(batch processing)으로 수행한 후, 통계분석 소프트웨어 프로그램인 SPSS(SPSS 18.0 version)를 이용하여 대응표본 T 검정을 수행하였다. 본 실시예에서 아로마틱 마린 토닉 향료 흡입 전(무자극)과 흡입 중(향자극)에 얻는 데이터 분석을 위한 뇌파지표의 종류는 표 3에, 그리고 각각의 뇌파 지표의 의미는 표 4에 나타내었다.In the present embodiment, the data processing obtained through the EEG measurement for the aromatic marine tonic combination fragrance 6 is performed by extracting only the representative EEG signals for 50 seconds from the EEG signals of the subject, and then performing a brain file processing program (batch processing), and then statistical analysis software Correspondence sample T test was performed using the program SPSS (SPSS 18.0 version). In this example, the types of EEG indicators for data analysis obtained before (no stimulation) and during inhalation (scent stimulation) of aromatic marine tonic fragrance are shown in Table 3, and the meaning of each EEG indicator is shown in Table 4.

데이터 분석에 사용된 뇌파 지표의 종류Types of EEG indicators used for data analysis No.No. 분석지표Analysis indicator 뇌파 분석 지표의 전체 이름Full name of EEG analysis indicator 파장대(Hz)Wavelength band (Hz) 1One ATAT Absolute Theta Power SpectrumAbsolute Theta Power Spectrum 4~84~8 22 AAAA Absolute Alpha Power SpectrumAbsolute Alpha Power Spectrum 8~138~13 33 ABAB Absolute Beta Power SpectrumAbsolute Beta Power Spectrum 13~3013~30 44 AGAG Absolute Gamma Power SpectrumAbsolute Gamma Power Spectrum 30~5030-50 55 AFAAFA Absolute Fast Alpha Power SpectrumAbsolute Fast Alpha Power Spectrum 11~1311~13 66 ASAASA Absolute Slow Alpha Power SpectrumAbsolute Slow Alpha Power Spectrum 8~118~11 77 ALBALB Absolute Low Beta Power SpectrumAbsolute Low Beta Power Spectrum 12~1512-15 88 AMBAMB Absolute Mid Beta Power SpectrumAbsolute Mid Beta Power Spectrum 15~2015-20 99 AHBAHB Absolute High Beta Power SpectrumAbsolute High Beta Power Spectrum 20~3020~30 1010 RTRT Relative Theta Power SpectrumRelative Theta Power Spectrum (4~8)/(4~50)(4~8)/(4~50) 1111 RARA Relative Alpha Power SpectrumRelative Alpha Power Spectrum (8~13)/(4~50)(8~13)/(4~50) 1212 RBRB Relative Beta Power SpectrumRelative Beta Power Spectrum (13~30)/(4~50)(13~30)/(4~50) 1313 RGRG Relative Gamma Power SpectrumRelative Gamma Power Spectrum (30~50)/(4~50)(30~50)/(4~50) 1414 RFARFA Relative Fast Alpha Power SpectrumRelative Fast Alpha Power Spectrum (11~13)/(4~50)(11~13)/(4~50) 1515 RSARSA Relative Slow Alpha Power SpectrumRelative Slow Alpha Power Spectrum (8~11)/(4~50)(8~11)/(4~50) 1616 RLBRLB Relative Low Beta Power SpectrumRelative Low Beta Power Spectrum (12~15)/(4~50)(12~15)/(4~50) 1717 RMBRMB Relative Mid Beta Power SpectrumRelative Mid Beta Power Spectrum (15~20)/(4~50)(15~20)/(4~50) 1818 RHBRHB Relative High Beta Power SpectrumRelative High Beta Power Spectrum (20~30)/(4~50)(20~30)/(4~50) 1919 RSTRST Ratio of SMR to ThetaRatio of SMR to Theta (12~15)/(4~8)(12~15)/(4~8) 2020 RMTRMT Ratio of Mid Beta to ThetaRatio of Mid Beta to Theta (15~20)/(4~8)(15~20)/(4~8) 2121 RSMTRSMT Ratio of (SMR-Mid Beta) to ThetaRatio of (SMR-Mid Beta) to Theta (12~20)/(4~8)(12~20)/(4~8) 2222 RAHBRAHB Ratio of Alpha to High BetaRatio of Alpha to High Beta (8~13)/(20~30)(8~13)/(20~30) 2323 SEF50SEF50 Spectral Edge Frequency 50%Spectral Edge Frequency 50% 4~504-50 2424 SEF90SEF90 Spectral Edge Frequency 90%Spectral Edge Frequency 90% 4~504-50 2525 ASEFASEF Spectral Edge Frequency 50% of Alpha Spectrum BandSpectral Edge Frequency 50% of Alpha Spectrum Band 8~138~13

데이터 분석에 사용된 뇌파 지표의 의미Meaning of EEG indicators used in data analysis No.No. 분석지표Analysis indicator 의미meaning 1One ATAT Theta파의 절대파워 (명상, 졸릴때)Absolute power of Theta wave (meditation, when sleepy) 22 AAAA Alpha파의 절대파워 (이완, 안정)Alpha wave absolute power (relaxation, stability) 33 ABAB Beta파의 절대파워 (긴장, 각성, 활성, 인지작용)Absolute power of Beta wave (tension, arousal, activity, cognitive function) 44 AGAG Gamma파의 절대파워 (고도의 인지작용 또는 불안, 흥분)Absolute power of Gamma waves (high cognitive function or anxiety, excitement) 55 AFAAFA Fast alpha파의 절대파워 (편안하면서 몰입)Absolute power of fast alpha wave (comfortable and immersive) 66 ASAASA Slow alpha파의 절대파워 (이완)Absolute power of slow alpha wave (relaxation) 77 ALBALB Low beta파의 절대파워, SMR파라고도 함 (주의나 경계)Absolute power of low beta wave, also called SMR wave (attention or boundary) 88 AMBAMB Mid beta파의 절대파워 (집중, 주의)Absolute power of mid beta wave (concentration, attention) 99 AHBAHB High beta파의 절대파워 (스트레스, 정신부하, 긴장)Absolute power of high beta wave (stress, mental load, tension) 1010 RTRT 전체 중 Theta파의 비율Theta wave's proportion of the total 1111 RARA 전체 중 Alpha파의 비율Ratio of Alpha wave among all 1212 RBRB 전체 중 Beta파의 비율Ratio of Beta wave among all 1313 RGRG 전체 중 Gamma파의 비율The ratio of Gamma waves in the total 1414 RFARFA 전체에서 Fast Alpha파의 비율Ratio of Fast Alpha wave in total 1515 RSARSA 전체에서 Slow Alpha파의 비율Ratio of slow alpha wave in the whole 1616 RLBRLB 전체에서 Low Beta파의 비율Ratio of low beta wave in the whole 1717 RMBRMB 전체에서 Mid Beta파의 비율Ratio of Mid Beta wave in total 1818 RHBRHB 전체에서 High Beta파의 비율Ratio of High Beta wave in the whole 1919 RSTRST 전체 중 SMR파에서 Theta파의 비율Ratio of SMR wave to Theta wave among all 2020 RMTRMT 전체 중 Mid Beta파에서 Theta파의 비율Ratio of Mid Beta wave to Theta wave among all 2121 RSMTRSMT SMR~Mid Beta파/Theta파 (뇌파집중지표)SMR~Mid Beta wave/Theta wave (EEG concentration indicator) 2222 RAHBRAHB Alpha파/High Beta파 (안정 및 이완도)Alpha wave/High Beta wave (stability and relaxation) 2323 SEF50SEF50 Median Frequency 뇌 활성도 (뇌파각성)Median Frequency Brain Activity (EEG Awakening) 2424 SEF90SEF90 Median Frequency 뇌 활성도 (정신부하, 스트레스)Median Frequency Brain activity (mental load, stress) 2525 ASEFASEF Alpha파의 SEF50 (쾌적성: Fast Alpha파가 많음)Alpha wave SEF50 (comfort: many Fast Alpha waves)

본 발명의 실시예 1에서 가장 선호도가 높았던 조합향료 6이 인간의 뇌파에 미치는 영향을 분석한 결과, 25개의 지표 중 RG 파워 스펙트럼, RLB 파워 스펙트럼, SEF50 파워 스펙트럼만 통계학적으로 유의성이 있는 것으로 나타났고(p<0.05), 나머지 22개의 파워스펙트럼은 향자극 전후에 큰 차이가 없었기 때문에 본 명세서에는 기술하지 않았다.As a result of analyzing the effect of the combination perfume 6, which had the highest preference in Example 1 of the present invention, on human brain waves, among the 25 indicators, only the RG power spectrum, RLB power spectrum, and SEF50 power spectrum were statistically significant. ( P <0.05), and the remaining 22 power spectrums were not described in the present specification because there was no significant difference before and after stimulus stimulation.

1. RG(Relative gamma power spectrum)1.RG (Relative gamma power spectrum)

조합향료 6을 흡입 전과 흡입 중에 뇌파를 측정한 결과, 전극 부착부위인 전전두엽 Afz과 전두엽 Fc6 부위에서 RG 지표가 통계학적으로 유의미(p<0.05)하게 증가하였다(표 5). RG 지표는 뇌파 스펙트럼에서 전체 주파수 영역의 절대파워에 대한 gamma 대역의 절대파워 비로서, gamma파 영역(30~50 Hz)을 전체 주파수 영역(4~50 Hz)으로 나누어 준 스펙트럼 값을 의미한다. Gamma파는 두뇌 활동 파장 중 가장 속파에 속하며, 정서적으로 초조한 상태이거나 추리, 판단 등의 고도의 인지작용 시 활성화된다고 알려져 있다. 조합향료 6의 흡입으로 RG가 증가하였다는 것은 뇌의 인지작용이 증가하였다는 것을 알 수 있다.As a result of measuring the EEG before and during the inhalation of the combination perfume 6, the RG index increased statistically significantly ( p <0.05) in the frontal lobe Afz and the frontal lobe Fc6, which are the electrode attachment sites (Table 5). The RG index is the ratio of the absolute power of the gamma band to the absolute power of the entire frequency range in the EEG spectrum, and refers to the spectrum value obtained by dividing the gamma wave region (30-50 Hz) by the total frequency domain (4-50 Hz). Gamma waves are among the fastest waves of brain activity, and are known to be activated during emotionally anxious conditions or high cognitive processes such as reasoning and judgment. It can be seen that the increase in RG by inhalation of the combination fragrance 6 increased the cognitive function of the brain.

조합향료 6의 향 흡입 전과 흡입 중의 RG(Relative gamma power spectrum) 변화Changes in Relative gamma power spectrum (RG) before and during inhalation of fragrance of combination fragrance 6 RG(Relative gamma power spectrum) Relative gamma power spectrum (RG) 뇌 위치Brain location 피험자 수Number of subjects 흡입 상태Suction condition 평균Average 표준편차Standard Deviation t-testt-test pp 중앙 전전두엽(Afz)Central prefrontal lobe (Afz) 2020 흡입 전Before inhalation 0.11970.1197 0.05180.0518 -2.2843-2.2843 0.03400.0340 흡입 중Inhaling 0.12940.1294 0.04690.0469 우측 전두엽(Fc6)Right frontal lobe (Fc6) 2020 흡입 전Before inhalation 0.11970.1197 0.05180.0518 -2.3012-2.3012 0.03290.0329 흡입 중Inhaling 0.12940.1294 0.04690.0469

2. RLB(Relative low beta power spectrum)2. Relative low beta power spectrum (RLB)

조합향료 6을 흡입 전과 흡입 중에 뇌파를 측정한 결과 전극 부탁부위인 전두엽 Fc2, 두정엽 Cz 부위에서 RLB 지표가 증가하였다(표 6). RLB 지표는 뇌파 스펙트럼에서 전체 주파수영역의 절대파워에 대한 low beta 대역의 절대파워 비로서 low beta파 영역(12~15 Hz)을 전체 주파수 영역(4~50 Hz)으로 나누어 준 스펙트럼 값을 의미한다. 조합향료 6의 흡입으로 RLB가 증가하였다는 것은 뇌의 집중도가 증가하였다는 것을 알 수 있다.As a result of measuring EEG before and during inhalation of the combination perfume 6, the RLB index was increased in the frontal lobe Fc2 and the parietal lobe Cz, which are the areas of the electrode attachment (Table 6). The RLB index is the ratio of the absolute power of the low beta band to the absolute power of the entire frequency region in the EEG spectrum, and refers to the spectrum value obtained by dividing the low beta wave region (12 to 15 Hz) by the total frequency region (4 to 50 Hz). . The increase in RLB by inhalation of the combination fragrance 6 indicates that the concentration of the brain increased.

조합향료 6의 향 흡입 전과 흡입 중의 RLB(Relative low beta power spectrum) 변화Changes in RLB (relative low beta power spectrum) before and during inhalation of fragrance in combination fragrance 6 RLB(Relative low beta power spectrum)Relative low beta power spectrum (RLB) 뇌 위치Brain location 피험자 수Number of subjects 흡입 상태Suction condition 평균Average 표준편차Standard Deviation t-testt-test pp 중앙 두정엽(Cz)Central parietal lobe (Cz) 2020 흡입 전Before inhalation 0.08220.0822 0.02380.0238 -2.2061-2.2061 0.03990.0399 흡입 중Inhaling 0.08760.0876 0.02060.0206 우측 전두엽(Fc2)Right frontal lobe (Fc2) 2020 흡입 전Before inhalation 0.08200.0820 0.02360.0236 -2.1897-2.1897 0.04120.0412 흡입 중Inhaling 0.08730.0873 0.02060.0206

3. SEF50(Spectral edge frequency 50%)3. SEF50(Spectral edge frequency 50%)

조합향료 6을 흡입 전과 흡입 중에 뇌파를 측정한 결과 전극 부착부위인 전두엽 Fc6 부위에서 SEF50 지표가 증가하였다(표 7). SEF50은 인지활동에 대한 대뇌피질의 활성을 알아보기 위한 기준척도로 작업부하도나 각성상태를 알아볼 수 있다. 뇌파 파워 스펙트럼 분포가 저주파에 비해서 고주파 쪽으로 얼마나 편향되었는지를 주파수로 정량화하는 방법으로 전체 주파수 영역에 대한 면적비로 표시되는데, SEF 값이 높을수록 파워 스펙트럼 분포에서 상대적으로 높은 주파수 성분이 많이 나왔음을 의미한다. SEF50 지표는 뇌의 각성을 나타내며, 영역구분에 의한 기존의 분석법보다 예리하고 심도 있는 지표로서 파워 스펙트럼에서 낮은 주파수 축에서부터 면적을 계산하고 그 면적이 전체 주파수 면적의 반이 되는 지점의 주파수 값을 의미한다. 조합향료 6의 흡입으로 SEF50이 증가하였다는 것은 뇌의 각성상태가 증진되었다는 것을 알 수 있다.As a result of measuring EEG before and during inhalation of the combination perfume 6, the SEF50 index was increased in the frontal lobe Fc6 region, which is the electrode attachment site (Table 7). The SEF50 is a reference scale for determining the activity of the cerebral cortex for cognitive activities, and it can check the workload or arousal state. It is a method of quantifying how much the EEG power spectrum distribution is deflected toward the high frequency compared to the low frequency, and is expressed as an area ratio to the entire frequency domain.The higher the SEF value, the higher the number of relatively high frequency components in the power spectrum distribution. . The SEF50 index represents the awakening of the brain, and is a sharper and deeper index than the conventional analysis method by domain classification. It means the frequency value at the point where the area is calculated from the lower frequency axis in the power spectrum and the area becomes half of the total frequency area. do. It can be seen that the increase in SEF50 by inhalation of the combination perfume 6 improved the arousal state of the brain.

조합향료 6의 향 흡입 전과 흡입 중의 SEF50(Spectral edge frequency 50%) 변화Changes in SEF50(Spectral edge frequency 50%) before and during inhalation of fragrance of combination fragrance 6 SEF50(Spectral edge frequency 50%)SEF50(Spectral edge frequency 50%) 뇌 위치Brain location 피험자 수Number of subjects 흡입 상태Suction condition 평균Average 표준편차Standard Deviation t-testt-test pp 우측 전두엽(Fc6)Right frontal lobe (Fc6) 2020 흡입 전Before inhalation 11.793511.7935 3.86093.8609 -2.2380-2.2380 0.03740.0374 흡입 중Inhaling 12.319912.3199 3.73943.7394

본 발명의 실시예에서 명확하게 나타난 바와 같이 조합향료 6은 흡입하였을 때 중앙 전전두엽(Afz) 및 우측 전두엽(Fc6) 부위에서 RG 지표, 중앙 두정엽(Cz) 및 우측 전두엽(Fc2) 부위에서 RLB 지표, 우측 전두엽(Fc6) 부위에서 SEF50 지표를 증가시켜 뇌의 인지능력 및 각성도를 증가시켜 집중력을 증진시켰다는 것을 나타낸다. 본 발명의 실시예의 모든 결과들은 조합향료 6의 흡입시 뇌의 집중력이 고도로 증가한다는 것을 나타낸다.As clearly shown in the examples of the present invention, when inhaled, the combination perfume 6 is an RG index in the central frontal lobe (Afz) and right frontal lobe (Fc6), an RLB index in the central parietal lobe (Cz) and right frontal lobe (Fc2), It indicates that the concentration was improved by increasing the SEF50 index in the right frontal lobe (Fc6) region, thereby increasing the brain's cognitive ability and arousal. All the results of the examples of the present invention indicate that the concentration of the brain is highly increased when the combination perfume 6 is inhaled.

Claims (7)

디하이드로 미르세놀(dihydro myrcenol) 2.2~2.8 중량%, 리나룰(linalool) 0.8~1.2 중량%, 리날릴 아세테이트(linalyl acetate) 0.8~1.2 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.3~2.7 중량%, 버독스(verdox) 2.8~3.2 중량%, 에틸 리나룰(ethyl linalool) 1.3~1.7 중량%, 베타 이오논(beta ionone) 2.8~3.2 중량%, 세드렘버(cedramber) 1.7~2.1 중량%, 릴리알(lilial) 7.7~8.3 중량%, 아이소 이 수퍼(iso e super) 9.2~9.8 중량%, 칼론(calone) 0.35~0.45 중량%, 암브로픽스(ambrofix) 1.8~2.2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.3~3.7 중량%, 헤디온(hedione) 10~11 중량%, 갈락솔라이드(galaxolide 50 ipm) 9.5~10.5 중량%, 토날라이드(tonalide) 3.5~4.5 중량%, 헬리오날(helional) 0.4~0.6 중량%, 박다놀(bacdanol) 0.8~1.2 중량%, 레몬 오일(lemon oil) 4.7~5.3 중량%, 시더우드 오일(cedarwood oil) 0.8~1.2 중량%, 로즈마리 오일(rosemary oil) 0.8~1.2 중량%, 버가못 오일(bergamot oil) 0.8~1.2 중량%, 디프로필렌 글리콜(dipropylene glycol) 25~26.5 중량% 및 블랙페퍼 오일(black pepper oil) 0.4~0.6 중량%가 혼합된 향료 혼합물을 유효성분으로 함유하는 집중력 증가용 향료 조성물.Dihydro myrcenol 2.2 to 2.8 wt%, linalool 0.8 to 1.2 wt%, linalyl acetate 0.8 to 1.2 wt%, methyl pamplemousse 2.3 to 2.7 wt %, verdox 2.8-3.2% by weight, ethyl linalool 1.3-1.7% by weight, beta ionone 2.8-3.2% by weight, cedramber 1.7-2.1% by weight, 7.7~8.3 wt% of lilial, 9.2~9.8 wt% of isoe super, 0.35~0.45 wt% of calone, 1.8~2.2 wt% of ambrofix, cis-3 -Hexenyl silicylate (cis-3-hexenyl salicylate) 3.3 to 3.7% by weight, hedione 10 to 11% by weight, galaxolide (50 ipm) 9.5 to 10.5% by weight, tonalide 3.5 to 4.5 wt%, helial 0.4 to 0.6 wt%, bacdanol 0.8 to 1.2 wt%, lemon oil 4.7 to 5.3 wt%, cedarwood oil 0.8 to 1.2 Wt%, rosemary oil 0.8~1.2 wt%, bergamot oil 0.8~1.2 wt%, dipropylene glycol 25~26.5 wt%, and black pepper oil 0.4~ A perfume composition for increasing concentration, containing a perfume mixture containing 0.6% by weight as an active ingredient. 삭제delete 제1항에 있어서, 상기 향료 조성물은 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)를 증가시키고, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)를 증가시키고, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)를 증가시키는 것을 특징으로 하는 집중력 증가용 향료 조성물.The method of claim 1, wherein the fragrance composition increases the relative gamma power spectrum (RG) in the central frontal lobe and the right frontal lobe, increases the relative low beta power spectrum (RLB) in the central and right frontal lobes, and SEF50 ( Fragrance composition for increasing concentration, characterized in that to increase the spectral edge frequency 50%). 제1항 또는 제3항에 따른 향료 조성물을 포함하는 집중력 증가용 건강기능식품.Health functional food for increasing concentration comprising the fragrance composition according to claim 1 or 3. 제1항 또는 제3항에 따른 향료 조성물을 포함하는 집중력 증가용 화장료 조성물.A cosmetic composition for increasing concentration, comprising the perfume composition according to claim 1 or 3. 향료 혼합물 총 중량 기준으로, 디하이드로 미르세놀(dihydro myrcenol) 2.2~2.8 중량%, 리나룰(linalool) 0.8~1.2 중량%, 리날릴 아세테이트(linalyl acetate) 0.8~1.2 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.3~2.7 중량%, 버독스(verdox) 2.8~3.2 중량%, 에틸 리나룰(ethyl linalool) 1.3~1.7 중량%, 베타 이오논(beta ionone) 2.8~3.2 중량%, 세드렘버(cedramber) 1.7~2.1 중량%, 릴리알(lilial) 7.7~8.3 중량%, 아이소 이 수퍼(iso e super) 9.2~9.8 중량%, 칼론(calone) 0.35~0.45 중량%, 암브로픽스(ambrofix) 1.8~2.2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.3~3.7 중량%, 헤디온(hedione) 10~11 중량%, 갈락솔라이드(galaxolide 50 ipm) 9.5~10.5 중량%, 토날라이드(tonalide) 3.5~4.5 중량%, 헬리오날(helional) 0.4~0.6 중량%, 박다놀(bacdanol) 0.8~1.2 중량%, 레몬 오일(lemon oil) 4.7~5.3 중량%, 시더우드 오일(cedarwood oil) 0.8~1.2 중량%, 로즈마리 오일(rosemary oil) 0.8~1.2 중량%, 버가못 오일(bergamot oil) 0.8~1.2 중량%, 디프로필렌 글리콜(dipropylene glycol) 25~26.5 중량% 및 블랙페퍼 오일(black pepper oil) 0.4~0.6 중량%를 혼합하여 제조하는 것을 특징으로 하는 집중력 증가 효과를 지니는 향료 혼합물의 제조방법.Based on the total weight of the fragrance mixture, dihydro myrcenol 2.2 to 2.8 wt%, linalool 0.8 to 1.2 wt%, linalyl acetate 0.8 to 1.2 wt%, methyl pamphlemos ( methyl pamplemousse) 2.3~2.7 wt%, verdox 2.8~3.2 wt%, ethyl linalool 1.3~1.7 wt%, beta ionone 2.8~3.2 wt%, cedramber ) 1.7~2.1 wt%, lilial 7.7~8.3 wt%, isoe super 9.2~9.8 wt%, calone 0.35~0.45 wt%, ambrofix 1.8~ 2.2 wt%, cis-3-hexenyl salicylate 3.3-3.7 wt%, hedione 10-11 wt%, galaxolide 50 ipm 9.5-10.5 wt %, tonalide 3.5-4.5% by weight, helional 0.4-0.6% by weight, bacdanol 0.8-1.2% by weight, lemon oil 4.7-5.3% by weight, cedarwood oil (cedarwood oil) 0.8 to 1.2 wt%, rosemary oil 0.8 to 1.2 wt%, bergamot oil 0.8 to 1.2 wt%, dipropylene glycol 25 to 26.5 wt% and black pepper oil (Black pepper oil) A method for producing a flavor mixture having an effect of increasing concentration, characterized in that prepared by mixing 0.4 to 0.6% by weight. 제6항의 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물.A fragrance mixture having an effect of increasing concentration, prepared by the method of claim 6.
KR1020190019916A 2019-02-20 2019-02-20 Aromatic aroma composition for enhancing concentration of human brain and uses thereof KR102151758B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190019916A KR102151758B1 (en) 2019-02-20 2019-02-20 Aromatic aroma composition for enhancing concentration of human brain and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190019916A KR102151758B1 (en) 2019-02-20 2019-02-20 Aromatic aroma composition for enhancing concentration of human brain and uses thereof

Publications (2)

Publication Number Publication Date
KR20200102037A KR20200102037A (en) 2020-08-31
KR102151758B1 true KR102151758B1 (en) 2020-09-03

Family

ID=72234424

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190019916A KR102151758B1 (en) 2019-02-20 2019-02-20 Aromatic aroma composition for enhancing concentration of human brain and uses thereof

Country Status (1)

Country Link
KR (1) KR102151758B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230128842A (en) 2022-02-28 2023-09-05 (주) 레비레스코 Natural aroma composition with anti-aging effect through activating stem cells and protecting from UV

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000355696A (en) 1999-04-12 2000-12-26 Kao Corp Perfume composition
JP2002154951A (en) 2000-09-08 2002-05-28 Hayashibara Bijutsu Minto:Kk Brain wave inhibitor
JP2005290379A (en) 2004-04-02 2005-10-20 Amorepacific Corp Perfume composition having physiological or psychological therapeutic effect
KR101349592B1 (en) 2013-05-22 2014-02-13 김성문 Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09302377A (en) * 1996-05-08 1997-11-25 Pola Chem Ind Inc Stress-relaxing perfume and composition containing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000355696A (en) 1999-04-12 2000-12-26 Kao Corp Perfume composition
JP2002154951A (en) 2000-09-08 2002-05-28 Hayashibara Bijutsu Minto:Kk Brain wave inhibitor
JP2005290379A (en) 2004-04-02 2005-10-20 Amorepacific Corp Perfume composition having physiological or psychological therapeutic effect
KR101349592B1 (en) 2013-05-22 2014-02-13 김성문 Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230128842A (en) 2022-02-28 2023-09-05 (주) 레비레스코 Natural aroma composition with anti-aging effect through activating stem cells and protecting from UV

Also Published As

Publication number Publication date
KR20200102037A (en) 2020-08-31

Similar Documents

Publication Publication Date Title
KR102151761B1 (en) Aquatic aroma composition for relaxation and enhancing concentration of human brain and uses thereof
KR101855737B1 (en) Aroma composition with buleberry flavor for relaxation and uses thereof
KR101077018B1 (en) Cosmetic Composition with Anti-stress and Relaxing Effect
KR20120131970A (en) Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same
KR101714543B1 (en) Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component
KR101843977B1 (en) Essential Oil Compound from Chamaecyparis obtusa and Cupressaceae and Abies koreana WILS to increase RSMT (ratio of (SMR~Mid beta) to theta), RB (relative beta power spectrum), RMT (ratio of mid beta to theta), AFA(absolute fast alpha power spectrum)
KR102151758B1 (en) Aromatic aroma composition for enhancing concentration of human brain and uses thereof
KR102060958B1 (en) Tropical passion flower aroma composition for enhancing concentration of human brain and uses thereof
KR102060960B1 (en) Aroma composition having fragrance of sensual luminous flower for brain pleasant and comfort
KR102060957B1 (en) Deep forest mix aroma composition for enhancing concentration of human brain and uses thereof
KR20190119824A (en) Perfume composition for decreasing relative theta wave and relative alpha wave of brainwave containing essential oil of Chrysanthemum indicum L and use thereof
KR101533673B1 (en) Perfume composition for expressing the fragrance of gardenia jasminoides Ellis for. Grandiflora Makino
KR102506628B1 (en) Aqua green Abies koreana aroma composition for enhancing comfort and concentration of human brain
KR102506624B1 (en) Fruity floral Abies koreana aroma composition for enhancing concentration of human brain
KR102570019B1 (en) A foot massage composition for aromatherapy
KR102340205B1 (en) Aroma composition with woody fragrance increasing brain concentration and awakening
KR102369379B1 (en) Aroma composition with gourmand floral fragrance for relieving stress
KR102363321B1 (en) Aroma composition with green citrus fragrance increasing brain refreshment and awakening
KR102001127B1 (en) Aroma composition for enhancing concentration by decreasing RSA power spectrum in the prefrontal lobe Fc5 site and increasing RHB power spectrum in the prefrontal lobe Af3 site and parietal lobe Af3 site and uses thereof
KR101877290B1 (en) Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof
KR101355307B1 (en) Perfume composition for expressing the fragrance of aconitum pseudolaeve nakai
KR101313255B1 (en) Fragrance compound containing the essential oil from Heracleum moellendorffii
KR101538417B1 (en) Composition of Cnidium officinale Makino essential oil and cosmetic having there
KR20210135741A (en) Aroma composition with gourmand floral fragrance releasing brain stress
KR20190061234A (en) Aroma composition enhances psychological stability of human by increasing the relative fast alpha activity at T8 region and decreasing the relative gamma activity at Cp6 region and uses thereof

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant